ACADIA Pharmaceuticals Inc

ACAD · Moat type: REGULIERUNG

MoatScore

2/10

Fair Value

22 USD

Margin of Safety

-17.7 %

Rating

MEIDEN

GESCHÄFTSMODELL ACADIA Pharmaceuticals develops and markets prescription medications for central nervous system disorders, generates revenues primarily through the sale of approved products, and invests in parallel in its clinical pipeline.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.